Showing results (141-150 of 185) with videos related to
Sort By:
Pageof 19
Paediatric Respiratory Reviews|September 13, 2021
Update in management of paediatric primary spontaneous pneumothoraxNathan Lieu, Peter Ngo, S Murthy Chennapragada, et al.Redox Biology|February 14, 2025
Astaxanthin protects against environmentally persistent free radical-induced oxidative stress in well-differentiated respiratory epitheliumAyaho Yamamoto, Peter D Sly, Lavrent Khachatryan, et al.Paediatric Respiratory Reviews|November 27, 2018
Disease caused by non-tuberculous mycobacteria in children with cystic fibrosisMimi Lu, Vishal Saddi, Philip N Britton, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 19, 2021
A Short extension to multiple breath washout provides additional signal of distal airway disease in people with CF: A pilot studyChristopher Short, Thomas Semple, Clare Saunders, et al.ERJ Open Research|November 11, 2021
Normal limits for oscillometric bronchodilator responses and relationships with clinical factorsKanika Jetmalani, Nathan J Brown, Chantale Boustany, et al.Vaccines|August 26, 2023
Clinical and Experimental Determination of Protection Afforded by BCG Vaccination against Infection with Non-Tuberculous Mycobacteria: A Role in Cystic Fibrosis?Sherridan Warner, Anneliese Blaxland, Claudio Counoupas, et al.European Journal of Pharmacology|April 13, 2021
Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell lineZara Sheikh, Peta Bradbury, Tristan A Reekie, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|August 24, 2018
Contribution of peripheral airway function to changes in FEV1/FVC and RV/TLC with agingChristopher Htun, Alun Pope, Samir Lahzami, et al.The Lancet. Respiratory Medicine|June 14, 2017
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trialFelix Ratjen, Christopher Hug, Gautham Marigowda, et al.Pediatric Pulmonology|July 25, 2017
Exercise capacity is not decreased in children who have undergone lung resection early in life for congenital thoracic malformations compared to healthy age-matched childrenAshlee Dunn, Kasey Pearce, Robin Callister, et al.Pageof 19